Home
Conditions
Tuberculosis (TB)

Clinical trial condition

Tuberculosis (TB)

Explore clinical trials studying Tuberculosis (TB). Study availability and eligibility vary by location and protocol.

39 public trials 14 recruiting studies

Refine in advanced search Browse all conditions

Tuberculosis (TB) trial results

Completed

Six-months Versus Nine-months ATT for Ocular TB

NCT06613919

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +17 more
Locations: University of Medicine Magway, EENT Hospital Nay Pyi Taw, Burma

LV Prasad Eye Institute Bhubaneswar, Odisha, India

Ramathibodi Hospital, Mahidol University Bangkok, Thailand

View Trial Details

Completed

Assessing the Ability of the T-SPOT®.TB Test

NCT03929705

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations: University of Cape Town Cape Town, South Africa

View Trial Details

Completed

Immunogenicity and Safety of a Candidate Tuberculosis (TB) Vaccine Given to Healthy Adults in a TB-endemic Region

NCT00600782

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +6 more
Locations: GSK Investigational Site Worcester, Western Province, South Africa

View Trial Details

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02A in Healthy PPD-positive Adults

NCT00146744

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations: GSK Investigational Site Lausanne, Switzerland

View Trial Details

Completed

Safety and Immunogenicity of GSK Biological's Candidate Tuberculosis Vaccine Mtb72F/AS02 in Healthy PPD-negative Adults.

NCT00291889

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations: GSK Investigational Site Ghent, Belgium

View Trial Details

Completed

Phase I Trial Evaluating Safety and Immunogenicity of MVA85A-IMX313 Compared to MVA85A in BCG Vaccinated Adults

NCT01879163

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations: Centre for Clinical Vaccinology and Tropical Medicine, University of Oxford Oxford, Oxfordshire, United Kingdom

Wellcome Trust Clinical Research Facility Birmingham, United Kingdom

View Trial Details

Completed

Safety and Immunogenicity of a Candidate Tuberculosis (TB) Vaccine Given to PPD-Negative Adults

NCT00730795

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations: GSK Clinical Trials Call Center Tacoma, Washington, United States

View Trial Details

Active, Not Recruiting

Pharmacist-led Digital Interventions to Improve Tuberculosis Treatment Adherence

NCT07069387

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +7 more
Locations: Sungai Buloh Hospital Sungai Buloh, Selangor, Malaysia

View Trial Details

Active, Not Recruiting

Safety and Immunogenicity of a Mycobacterium Tuberculosis Vaccine MTBVAC in Healthy Indian Adults and Adolescents (BBV169/2024)

NCT06997367

Conditions: Actinomycetales Infections, Bacterial Infections, Bacterial Infections and Mycoses, +5 more
Locations: Guru Teg Bahadur Hospital Delhi, India

AIIMS-Delhi New Delhi, India

View Trial Details

Tuberculosis (TB)

Tuberculosis (TB) trial results

Related conditions